Stay updated with breaking news from Peter Hecht. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAMBRIDGE, Mass., March 27, 2023 -- Cyclerion Therapeutics, Inc. , a clinical-stage biopharmaceutical company on a mission to develop treatments for serious diseases, today announced that the U.S.... | March 27, 2023
The FDA has granted Orphan Drug designation to zagociguat for the treatment of mitochondrial disease.
BOSTON, Oct. 24, 2022 /PRNewswire/ -- Ariadne Labs today announced Ambassador Román Macaya, PhD, MBA, as a new member of its Advisory Board. Forme...
Recent positive MELAS clinical study data drive urgency to deliver potential first-ever therapy for patients with rare, genetic mitochondrial diseases ...
Cyclerion Therapeutics Provides Additional Positive CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation - read this article along with other careers information, tips and advice on BioSpace